We then divided their expression levels into two categories (low vs. high) and found that ROC1 and Gli2 expression was low, but SUFU expression was high in the low-grade bladder cancer tissues compared with those in high-grade tumors (Fig. 5a). The gene discussed is SUFU; the disease is urinary bladder cancer.